Bahtiyar Yilmaz

Publications

• Glycan-Based Shaping Of The Microbiota During Primate Evolution
• Glycan-based shaping of the microbiota during primate evolution
• Compartmentalization of intestinal bacteria by hepatic ILC3s prevents infections after surgery
• The Swiss Primary Hypersomnolence and Narcolepsy Cohort study (SPHYNCS): Study protocol for a prospective, multicentre cohort observational study
• Regular testing of asymptomatic healthcare workers identifies cost-efficient SARS-CoV-2 preventive measures
• A trade-off between resistance to infection and reproduction in primate evolution
• Loss of α-gal during primate evolution enhanced antibody-effector function and resistance to bacterial sepsis
• Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease
• Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet compared with traditional dietary advice for diarrhea-predominant irritable bowel syndrome: A parallel-group, randomized controlled trial with analysis of clinical and microbiological factors associated with patient outcomes
• Long-term evolution and short-term adaptation of microbiota strains and sub-strains in mice
• Intestinal mucus and gut-vascular barrier: FxR-modulated entry sites for pathological bacterial translocation in liver cirrhosis
• Dysbiotic microbiota interactions in Crohn’s disease
• Vegetarian or gluten-free diets in patients with inflammatory bowel disease are associated with lower psychological well-being and a different gut microbiota, but no beneficial effects on the course of the disease
• Fatigue in inflammatory bowel disease and its impact on daily activities
• A single nucleotide polymorphism in the gene for GPR183 increases its surface expression on blood lymphocytes of patients with inflammatory bowel disease
• Antibodies set boundaries limiting microbial metabolite penetration and the resultant mammalian host response
• Effects of anti-TNF therapy and immunomodulators on anxiety and depressive symptoms in patients with inflammatory bowel disease: a 5-year analysis
• Neuronal programming by microbiota enables environmental regulation of intestinal motility
• Intestinal microbiota drives cholestasis-induced specific hepatic gene expression patterns
• An improved semi-quantitative spot assay to analyse chronological lifespan in yeast
• Nlrp6- and ASC-Dependent Inflammasomes Do Not Shape the Commensal Gut Microbiota Composition
• IgA Function in Relation to the Intestinal Microbiota
• A new cost and time effective method for multilocus microsatellite typing (MLMT) studies: Application of Leishmania tropica isolates and clinical samples from Turkey
• D-lactic acidosis: Successful suppression of D-lactate-producing lactobacillus by probiotics
• Maternal γδ T cells shape offspring pulmonary type 2 immunity in a microbiota-dependent manner
• ILC3s restrict the dissemination of intestinal bacteria to safeguard liver regeneration after surgery
• FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis
• Neuronal programming by microbiota regulates intestinal physiology
• Different effects of constitutive and induced microbiota modulation on microglia in a mouse model of Alzheimer’s disease
• Diet and Inflammatory Bowel Disease: What Quality Standards Should Be Applied in Clinical and Laboratory Studies?
• Association of Alterations in Intestinal Microbiota With Impaired Psychological Function in Patients With Inflammatory Bowel Diseases in Remission
• Crosstalk between γδ T cells and the microbiota
• Roux-en-Y gastric bypass with a long versus a short biliopancreatic limb improves weight loss and glycemic control in obese mice
• Antenatal and postpartum immunological markers levels in women with HIV infection and malnutrition in a low resource setting: A pilot study
• Microbial drivers of DSS variability
• Development of non-alcoholic steatohepatitis is associated with gut microbiota but not oxysterol synthesis
• Gut microbiota drives age-related oxidative stress and mitochondrial damage in microglia via the metabolite N6-carboxymethyllysine
• Physiological and Molecular Characterization of an Oxidative Stress-Resistant Saccharomyces cerevisiae Strain Obtained by Evolutionary Engineering.
• Microbiota Control of Malaria Transmission
• Antibodies that l IgA te our intestinal microbes
• The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients
• Antibodies Set Boundaries Limiting Microbial Metabolite Penetration and the Resultant Mammalian Host Response.
• Gut Microbiota and Iron: The Crucial Actors in Health and Disease
• Microbial network disturbances in relapsing refractory Crohn’s disease
• Publisher Correction: Microbial network disturbances in relapsing refractory Crohn’s disease
• Mucosal or systemic microbiota exposures shape the B cell repertoire
• Inflammatory bowel disease in sub-Saharan Africa: a protocol of a prospective registry with a nested case–control study
• Maternal γδ T cells shape offspring pulmonary type-2 immunity in a microbiota-dependent manner
• Modulation of the Mucosa-Associated Microbiome Linked to the PTPN2 Risk Gene in Patients with Primary Sclerosing Cholangitis and Ulcerative Colitis
• Pilot Sub-Study of the Effect of Hepatitis C Cure by Glecaprevir/Pibrentasvir on the Gut Microbiome of Patients with Chronic Hepatitis C Genotypes 1 to 6 in the Mythen Study
• Gut Microbiota Elicits a Protective Immune Response against Malaria Transmission
• What drives you?
• Evolutionary engineering of oxidative stress resistant S. cerevisiae under continuous stress conditions
• Predominant effect of ischemic preconditioning on short term reperfusion following ischemia
• A Natural Protective Mechanism Against Malaria
• D-Lactate: Implications for Gastrointestinal Diseases
• Different effects of constitutive and induced microbiota modulation on microglia in a mouse model of Alzheimer’s disease
• Associations between gut microbiota characteristics and non‐motor symptoms following pharmacological and surgical treatments in Parkinson's disease patients